Approach to Cohort-Wide Re-Analysis of Exome Data in 1000 Individuals with Neurodevelopmental Disorders.


Journal

Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097

Informations de publication

Date de publication:
22 12 2022
Historique:
received: 25 10 2022
revised: 02 12 2022
accepted: 19 12 2022
entrez: 21 1 2023
pubmed: 22 1 2023
medline: 25 1 2023
Statut: epublish

Résumé

The re-analysis of nondiagnostic exome sequencing (ES) has the potential to increase diagnostic yields in individuals with rare diseases, but its implementation in the daily routines of laboratories is limited due to restricted capacities. Here, we describe a systematic approach to re-analyse the ES data of a cohort consisting of 1040 diagnostic and nondiagnostic samples. We applied a strict filter cascade to reveal the most promising single-nucleotide variants (SNVs) of the whole cohort, which led to an average of 0.77 variants per individual that had to be manually evaluated. This variant set revealed seven novel diagnoses (0.8% of all nondiagnostic cases) and two secondary findings. Thirteen additional variants were identified by a scientific approach prior to this re-analysis and were also present in this variant set. This resulted in a total increase in the diagnostic yield of 2.3%. The filter cascade was optimised during the course of the study and finally resulted in sensitivity of 85%. After applying the filter cascade, our re-analysis took 20 h and enabled a workflow that can be used repeatedly. This work is intended to provide a practical recommendation for other laboratories wishing to introduce a resource-efficient re-analysis strategy into their clinical routine.

Identifiants

pubmed: 36672771
pii: genes14010030
doi: 10.3390/genes14010030
pmc: PMC9858523
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Nat Genet. 2020 May;52(5):473-481
pubmed: 32367058
Genet Med. 2017 Feb;19(2):209-214
pubmed: 27441994
Genet Med. 2021 Aug;23(8):1381-1390
pubmed: 34012068
Genet Med. 2021 Feb;23(2):384-395
pubmed: 33173220
Genet Med. 2021 Mar;23(3):534-542
pubmed: 33110267
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Nucleic Acids Res. 2005 Jan 1;33(Database issue):D514-7
pubmed: 15608251
Am J Hum Genet. 2020 Oct 1;107(4):753-762
pubmed: 32910914
Bioinformatics. 2019 Jan 15;35(2):337-339
pubmed: 29992288
Hum Mutat. 2003 Jun;21(6):577-81
pubmed: 12754702
Clin Genet. 2018 Dec;94(6):495-501
pubmed: 30125339
Mol Med. 2022 Mar 26;28(1):38
pubmed: 35346031
Am J Hum Genet. 2009 Apr;84(4):524-33
pubmed: 19344873
Genet Med. 2022 Aug;24(8):1618-1629
pubmed: 35550369
Am J Hum Genet. 2009 Oct;85(4):457-64
pubmed: 19800049
Eur J Hum Genet. 2021 Sep;29(9):1337-1347
pubmed: 34075210
Nat Genet. 2018 Oct;50(10):1442-1451
pubmed: 30224647
Nat Genet. 2014 Sep;46(9):944-50
pubmed: 25086666
BMC Med Genomics. 2019 Jan 21;12(1):11
pubmed: 30665423
BMC Med Genet. 2015 Nov 05;16:102
pubmed: 26542245
Genet Med. 2018 Oct;20(10):1216-1223
pubmed: 29323667
Am J Hum Genet. 2020 Aug 6;107(2):352-363
pubmed: 32693025
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Sci Transl Med. 2015 Jan 14;7(270):270ra6
pubmed: 25589632
Nature. 2020 May;581(7809):434-443
pubmed: 32461654
Genet Med. 2021 Feb;23(2):408-414
pubmed: 33033404
Front Genet. 2019 Aug 20;10:736
pubmed: 31481971
Nucleic Acids Res. 2020 Jan 8;48(D1):D835-D844
pubmed: 31777943
Nucleic Acids Res. 2016 Jan 4;44(D1):D862-8
pubmed: 26582918
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
Genet Med. 2019 Jun;21(6):1267-1270
pubmed: 31015575
Cell. 2019 Jan 24;176(3):535-548.e24
pubmed: 30661751
Nat Genet. 2019 Nov;51(11):1560-1565
pubmed: 31676867
N Engl J Med. 2019 Jun 20;380(25):2478-2480
pubmed: 31216405
PLoS One. 2015 Feb 09;10(2):e0115692
pubmed: 25664462
Nucleic Acids Res. 2021 Jan 8;49(D1):D1207-D1217
pubmed: 33264411
Front Med. 2021 Dec;15(6):877-886
pubmed: 34825340
Nat Biotechnol. 2017 Apr 11;35(4):316-319
pubmed: 28398311
Lancet. 2015 Apr 4;385(9975):1305-14
pubmed: 25529582
Nat Biotechnol. 2011 Jan;29(1):24-6
pubmed: 21221095
Mol Genet Genomic Med. 2020 Nov;8(11):e1508
pubmed: 32969205
Med Genet. 2018;30(3):323-327
pubmed: 30459488
Am J Hum Genet. 2016 Jan 7;98(1):149-64
pubmed: 26748517
N Engl J Med. 2012 Feb 16;366(7):619-28
pubmed: 22335739
PLoS Genet. 2017 Oct 25;13(10):e1006864
pubmed: 29069077
Eur J Hum Genet. 2018 May;26(5):740-744
pubmed: 29453418
Bioinformatics. 2018 Sep 15;34(18):3094-3100
pubmed: 29750242

Auteurs

Insa Halfmeyer (I)

Institute of Human Genetics, University of Leipzig Medical Center, 04103 Leipzig, Germany.

Tobias Bartolomaeus (T)

Institute of Human Genetics, University of Leipzig Medical Center, 04103 Leipzig, Germany.

Bernt Popp (B)

Institute of Human Genetics, University of Leipzig Medical Center, 04103 Leipzig, Germany.
Center of Functional Genomics, Berlin Institute of Health at Charité, Universitätsmedizin Berlin, Hessische Straße 4A, 10115 Berlin, Germany.

Maximilian Radtke (M)

Institute of Human Genetics, University of Leipzig Medical Center, 04103 Leipzig, Germany.

Tobias Helms (T)

Limbus Medical Technologies GmbH, Neuer Markt 9/10, 18055 Rostock, Germany.

Julia Hentschel (J)

Institute of Human Genetics, University of Leipzig Medical Center, 04103 Leipzig, Germany.

Denny Popp (D)

Institute of Human Genetics, University of Leipzig Medical Center, 04103 Leipzig, Germany.

Rami Abou Jamra (RA)

Institute of Human Genetics, University of Leipzig Medical Center, 04103 Leipzig, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH